Tin tức & Cập nhật

Blood-based biomarkers (BBBs) may potentially aid earlier detection of Alzheimer’s disease (AD) following a recent revision of diagnostic criteria supporting core biomarker–based diagnosis. Initial local experience with lecanemab, a disease-modifying therapy (DMT) for patients with mild cognitive impairment or mild dementia due to AD, was shared at Advances in Medicine (AIM) 2025.

Hospital isolation for COVID-19 caused heightened anxiety in families, particularly children, during the early phase of the pandemic, according to a Singapore study.